Lannett (ACO) Worth Watching: Stock Rises 6.1% - Tale of the Tape


Shutterstock photo

Lannett Company, Inc. ( LCI ) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend of the company as the stock has gained nearly 28% since Feb 6.

This pharmaceutical company has seen four positive estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved considerably higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday's price action can turn into more strength down the road.

Lannett Company currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other top-ranked Med-Drug stocks include Endocyte, Inc. ( ECYT ), Ariad Pharmaceuticals Inc. ( ARIA ) and BioCryst Pharmaceuticals, Inc. ( BCRX ). While ARIA and BCRX carry a Zacks Rank #2 (Buy), ECYT sports the same Zacks Rank as Lannett.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

ARIAD PHARMA (ARIA): Free Stock Analysis Report

BIOCRYST PHARMA (BCRX): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report

LANNETT INC (LCI): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: ARIA , BCRX , ECYT , LCI

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by